Impact of SLN biopsy vs Lymphadenectomy in Endometrial Cancer with Dimitrios Nasioudis


Manage episode 297814741 series 1426075
By BMJ talk medicine and BMJ Group. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Dimitrios Nasioudis to discuss the impact of SLN biopsy versus lymphadenectomy in endometrial cancer. Dr. Nasioudis is a resident at the Hospital of the University of Pennsylvania, Philadelphia. His current interests include population science and outcomes research with an emphasis on rare gynecologic tumors. Dimitrios Nasioudis (@Dnasioudis / @PennMedicine) Highlights: - Sentinel lymph node biopsy has been established as a minimalistic approach to endometrial cancer staging, with excellent diagnostic accuracy. - Data on the long-term oncologic and patient reported outcomes are greatly warranted. - For patients with stage IIIC endometrial cancer, based on a large dataset, overall survival was comparable between the sentinel lymph node biopsy alone and systematic lymphadenectomy groups.

3608 episodes